PS Ratio:
19.31+0.34(+1.79%)Summary
- As of today, NTLA price to sales ratio is 19.31, with a rise of +0.34 (+1.79%) during the most recent trading session on December 24, 2025.
- Over the past year, NTLA PS ratio has dropped by -9.17 (-32.20%).
- NTLA PS ratio is now -94.98% below its all-time high of 384.29.
Performance
NTLA PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
NTLA PS Ratio Trends
| PeriodPeriod | PS RatioPS Ratio | PricePrice | Market CapMarket Cap | TTM RevenueTTM Revenue |
|---|---|---|---|---|
| 1D1 Day | +1.8% | +1.8% | +1.8% | +8.8% |
| 1M1 Month | +14.9% | +14.8% | +14.8% | - |
| 3M3 Months | -46.5% | -46.0% | -41.7% | +8.8% |
| 6M6 Months | -11.2% | +0.2% | +12.1% | - |
| YTDYTD | -6.1% | -17.8% | -6.6% | - |
| 1Y1 Year | -32.2% | -20.4% | -9.5% | +33.5% |
| 5Y5 Years | -70.0% | -84.6% | -72.3% | -7.7% |
NTLA PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 19.61 | -1.5% | 16.31 | +18.4% |
| 3M | 3-Month | 56.32 | -65.7% | 16.19 | +19.3% |
| 6M | 6-Month | 56.32 | -65.7% | 16.19 | +19.3% |
| 1Y | 1-Year | 56.32 | -65.7% | 14.27 | +35.3% |
| 3Y | 3-Year | 86.90 | -77.8% | 14.27 | +35.3% |
| 5Y | 5-Year | 384.29 | -95.0% | 14.27 | +35.3% |
| All-Time | All-Time | 384.29 | -95.0% | 11.06 | +74.6% |
NTLA PS Ratio History
| Date | Value |
|---|---|
| 2025 | 19.31(-6.1%) |
| 2024 | 20.56(-73.7%) |
| 2023 | 78.17(+34.1%) |
| 2022 | 58.31(-78.1%) |
| 2021 | 266.46(+328.9%) |
| Date | Value |
|---|---|
| 2020 | 62.13(+263.8%) |
| 2019 | 17.08(-12.6%) |
| 2018 | 19.54(-37.4%) |
| 2017 | 31.19(+8.9%) |
| 2016 | 28.65 |
FAQ
- What is Intellia Therapeutics, Inc. price to sales ratio?
- What is the all-time high PS ratio for Intellia Therapeutics, Inc.?
- What is NTLA price to sales ratio year-to-date change?
- What is Intellia Therapeutics, Inc. PS ratio year-on-year change?
What is Intellia Therapeutics, Inc. price to sales ratio?
The current PS ratio of NTLA is 19.31
What is the all-time high PS ratio for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high price to sales ratio is 384.29
What is NTLA price to sales ratio year-to-date change?
Intellia Therapeutics, Inc. price to sales ratio has changed by -1.25 (-6.08%) since the beginning of the year
What is Intellia Therapeutics, Inc. PS ratio year-on-year change?
Over the past year, NTLA price to sales ratio has changed by -9.17 (-32.20%)